morphosys share price

MOR:Xetra Stock Quote – MorphoSys AG – Bloomberg Markets

Stock analysis for MorphoSys AG (MOR:Xetra) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Morphosys NPV Share Price –

The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of

Stock information | MorphoSys AG

MorphoSys AG shares opened the reporting year at a share price of € 48.75. After a volatile start in the first weeks of 2017, the shares marked their low for the year on February 6 at € 47.60. The shares then trended higher in line with the TecDAX before breaking out in September with price performance far outpacing the benchmark index.

MORPHOSYS AG Share Price – Stockopedia

Latest MorphoSys AG Share Price – Live MOR share price quotes, charts, profile, RNS & company financials for ETR:MOR. Focus on All Regions. BRIEF-Morphosys Says Its Licensee Janssen Has Expanded Clinical Development Of Guselkumab Into Ulcerative Colitis 12th Dec ’18

MorphoSys (XTRA:MOR) – Share price, News & Analysis

The current share price of MorphoSys is above its future cash flow value. Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth. PRICE RELATIVE TO MARKET

Stock | MORPHOSYS Stock Price Today | Markets Insider

Quotes for MorphoSys Stock. Price 102.25 Day’s Range 100.40 – 102.50 Trade Time 04:00PM 52-week Range 56.44 – 124.70 Trade Date 08/23/2018 52-week Perf. The price of 102.25 EUR on the exchange Stuttgart equals a price of 118.17 USD at the current exchange rate for EUR/USD.

MPSYF Stock Price – MorphoSys AG Stock Quote (U.S.: OTC

MorphoSys AG stock price, stock quotes and financial overviews from MarketWatch. MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications.

MOR.DE : Summary for MORPHOSYS AG O.N. – Yahoo Finance

U.S. Markets open in 4 hrs 15 mins. Novartis said on Thursday it will pay 95 million euros to Galapagos and MorphoSys to license a prospective medicine targeting the skin condition atopic dermatitis, as the Swiss drugmaker strengthens its

MOR Historical Prices | MorphoSys AG Stock – Yahoo Finance

Discover historical prices for MOR stock on Yahoo Finance. View daily, weekly or monthly format back to when MorphoSys AG stock was issued.

MorphoSys – Official Site

MorphoSys is dedicated to become a fully integrated biopharmaceutical company. Our business strategy brings more value for patients, investors and partners.